5-Aryl-indan-1-one and analogs useful as progesterone...

Details 5-Aryl-indan-1-one and analogs useful as progesterone... 5-Aryl-indan-1-one and analogs useful as progesterone...

2008-01-15

2008-01-15

Anderson, Rebecca (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S235000, C548S247000, C549S078000

Reexamination Certificate

active

11522862

ABSTRACT:
Compounds of formula I or II are provided, wherein R1-R8are defined herein, and pharmaceutical compositions and kits containing these compounds. Also provided are methods of inducing contraception, providing hormone replacement therapy, treating cycle-related symptoms, or treating or preventing benign or malignant neoplastic disease using the compounds of formula I, formula II, or formula III, wherein R1-R9are defined herein:

REFERENCES:
patent: 5329050 (1994-07-01), Weisse et al.
patent: 5360936 (1994-11-01), Weisse et al.
patent: 5578646 (1996-11-01), Pineyro-Lopez
patent: 5719136 (1998-02-01), Chwalisz et al.
patent: 6288126 (2001-09-01), LeSuisse et al.
patent: 6355648 (2002-03-01), Fensome et al.
patent: 6391907 (2002-05-01), Fensome et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6566358 (2003-05-01), Zhang et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 6608068 (2003-08-01), Fensome et al.
patent: 6713478 (2004-03-01), Zhang et al.
patent: 6841568 (2005-01-01), Fensome et al.
patent: 6946454 (2005-09-01), Fensome et al.
patent: 7081457 (2006-07-01), Zhang et al.
patent: 7084168 (2006-08-01), Fensome et al.
patent: 7091234 (2006-08-01), Fensome et al.
patent: 2004/0186101 (2004-09-01), Zhang et al.
patent: 2005/0085470 (2005-04-01), Zhang et al.
patent: 2005/0171186 (2005-08-01), Fensome et al.
patent: 2006/0030615 (2006-02-01), Fensome et al.
patent: 2006/0142280 (2006-06-01), Zhang et al.
patent: 2006/0160882 (2006-07-01), Fensome et al.
patent: 467407 (1995-11-01), None
patent: 0568879 (1996-07-01), None
patent: 587107 (1996-08-01), None
patent: 1175397 (2004-08-01), None
patent: 2 705 671 (1994-02-01), None
patent: WO 97/27846 (1997-07-01), None
patent: WO 98/13061 (1998-04-01), None
patent: WO 98/22436 (1998-05-01), None
patent: WO 98/44797 (1998-10-01), None
patent: WO 98/09940 (1998-12-01), None
patent: WO 99/18079 (1999-04-01), None
patent: WO 99/61413 (1999-12-01), None
patent: WO 00/37433 (2000-06-01), None
patent: WO 00/66554 (2000-11-01), None
patent: WO 00/66555 (2000-11-01), None
patent: WO 00/66556 (2000-11-01), None
patent: WO 00/66570 (2000-11-01), None
patent: WO 00/66571 (2000-11-01), None
patent: WO 00/78724 (2000-12-01), None
patent: WO 03/091225 (2003-11-01), None
patent: WO 2006/023107 (2006-03-01), None
Horwitz et al, Progestins, Progesterone Receptors, and Breast Cancer, Hormones and Cancer, 283-306, 1996.
Kekkonen et al, Sequential Regimen of the Antiprogesterone RU486 and Synthetic Progestin for Contraception, Fertility and Sterility, vol. 60, No. 4, (Oct. 1993).
Kettel et al, Endocrine Responses to Long-term Administration of the Antiprogesterone RU486 in Patients with Pelvic Endometriosis, Fertility and Sterility, vol. 56, No. 3, (Sep. 1991).
Mangelsdorf et al, The Nuclear Receptor Superfamily: The Second Decade, Cell, vol. 83, 835-839, (Dec. 15, 1995).
Michna et al, Differentiation Therapy with Progesterone Antagonists, Ann. N.Y. Acad. Sci. 761, 224, (1995).
Murphy et al, Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 486, Journal of Clinical Endocrinology and Metabolism, vol. 76, No. 2, 513-517, (1993).
Ulmann et al, Clinical Uses of Mifepristone (MFP), Ann. N.Y. Acad. Sci. 261, 248, (1995).

Affiliated with

Also associated with

Rating

5-Aryl-indan-1-one and analogs useful as progesterone... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-Aryl-indan-1-one and analogs useful as progesterone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Aryl-indan-1-one and analogs useful as progesterone... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3921144